Correlation between treatments and outcomes of patients with EGFR-mutated non-small-cell lung cancer that transitioned into small-cell lung cancer: an international retrospective study

肺癌 医学 癌症 肿瘤科 回顾性队列研究 内科学 表皮生长因子受体 化疗 胃肠病学
作者
Chiara Catania,Stephen V. Liu,Marina Chiara Garassino,A. Delmonte,Vieri Scotti,F. Cappuzzo,C. Genova,Alessandro Russo,Marco Russano,Chiara Bennati,Ida Colantonio,Stefania Martini,Miguel Antonio Agüero Pino,Fabio Conforti,Laura Pala,G. Minuti,F. Citarella,Emanuela Olmetto,Alessandra Esposito,Priscilla Cascetta
出处
期刊:ESMO open [Elsevier BV]
卷期号:10 (7): 105326-105326 被引量:31
标识
DOI:10.1016/j.esmoop.2025.105326
摘要

BACKGROUND: Histological transformation to small-cell lung cancer (SCLC) is an under-recognized but clinically relevant mechanism of resistance in epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC). While platinum-based chemotherapy (CT) has emerged as standard treatment after small-cell transformation, optimal treatment strategies are not defined, particularly with regard to the role of immune checkpoint inhibitors (ICIs) or continuation of EGFR-tyrosine kinase inhibitors (TKIs). MATERIALS AND METHODS: We conducted an international, retrospective, observational study on patients with EGFR-mutated NSCLC that transformed to SCLC, focusing on treatment and outcomes. RESULTS: Twenty-five patients across 11 centers were included. Twenty-four changed systemic treatment following SCLC transformation: CT (12 patients), CT plus EGFR-TKI (5 patients), CT plus ICI (6 patients), or CT plus ICI plus EGFR-TKI (1 patient). Median follow-up was 9 months (range 1-45 months). All patients experienced relapse with a median progression-free survival of 2 months [95% confidence interval (CI) 2-3 months] and 23 patients died, with a median overall survival (OS) of 9 months (95% CI 7-16 months). Median OS was comparable between patients treated with CT alone [9.5 months; 95% CI 5 months-not reached (NR)], CT plus EGFR-TKI (8 months; 95% CI 8 months-NR), and CT plus ICI (10 months; 95% CI 7 months-NR). Three patients survived >24 months from SCLC transformation; these patients were treated with CT alone (one patient), CT plus EGFR-TKI (one patient), and CT plus ICI and EGFR-TKI (one patient). OS was longer if SCLC transformation occurred >12 months from initial NSCLC diagnosis (19 patients) versus those with transformation within 12 months (6 patients): 31 versus 8 months (P < 0.001). CONCLUSIONS: The prognosis of patients with transformed SCLC remains poor, with only a minority achieving meaningful survival. Survival was similar in patients treated with CT alone or with the addition of ICI or EGFR-TKI. A time interval >12 months between NSCLC diagnosis and SCLC transformation was associated with longer survival and may reflect a different biology than early transformation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
疯狂学习的小聂完成签到,获得积分10
刚刚
手术缝合线完成签到 ,获得积分10
1秒前
1秒前
wanci的应助被晴天采纳,获得10
1秒前
Lizhuo完成签到,获得积分10
1秒前
银子吃好的完成签到,获得积分0
1秒前
www完成签到 ,获得积分10
1秒前
颿曦完成签到,获得积分10
1秒前
方百招完成签到,获得积分10
2秒前
Akoasm发布了新的文献求助10
2秒前
虚幻的觅露完成签到,获得积分10
2秒前
好运常在完成签到,获得积分10
3秒前
君为臣纲完成签到,获得积分0
3秒前
aaaddwdf完成签到,获得积分10
4秒前
拼搏的飞薇完成签到,获得积分10
4秒前
Archer完成签到,获得积分10
4秒前
从容的尔云完成签到 ,获得积分10
4秒前
科研菜鸟望毕业完成签到,获得积分10
4秒前
12345完成签到,获得积分10
4秒前
dandelion发布了新的文献求助10
5秒前
残夜完成签到,获得积分10
5秒前
youyuguang完成签到 ,获得积分10
5秒前
打野速度完成签到 ,获得积分10
5秒前
shuke完成签到,获得积分10
5秒前
明月完成签到,获得积分10
6秒前
章1完成签到,获得积分10
6秒前
iceeer完成签到,获得积分10
6秒前
落幕熊猫完成签到,获得积分10
6秒前
彭于晏的应助被小木虫采纳,获得10
7秒前
Zara完成签到,获得积分10
7秒前
香蕉白猫完成签到,获得积分10
7秒前
啵啵奶冻完成签到 ,获得积分10
9秒前
虚心的冰巧完成签到,获得积分10
10秒前
jcs324完成签到,获得积分10
10秒前
自觉沛文完成签到,获得积分10
10秒前
受伤问凝完成签到 ,获得积分10
10秒前
Akoasm完成签到,获得积分10
10秒前
薇子完成签到,获得积分10
11秒前
aaaaaa完成签到,获得积分10
11秒前
wqwq69完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180135
求助须知:如何正确求助?哪些是违规求助? 9570290
关于积分的说明 21809391
捐赠科研通 7776237
什么是DOI,文献DOI怎么找? 3433266
关于科研通互助平台的介绍 2557465
邀请新用户注册赠送积分活动 2479039